PharmAust Limited (PAA.AX)

AUD 0.23

(6.98%)

Long Term Debt Summary of PharmAust Limited

  • PharmAust Limited's latest annual long term debt in 2024 was - AUD , down 0.0% from previous year.
  • PharmAust Limited's latest quarterly long term debt in 2024 FY was - AUD , down -100.0% from previous quarter.
  • PharmAust Limited reported annual long term debt of 890.5 Thousand AUD in 2023, down -14.13% from previous year.
  • PharmAust Limited reported annual long term debt of 1.03 Million AUD in 2022, down -8.34% from previous year.
  • PharmAust Limited reported quarterly long term debt of - AUD for 2024 Q2, down 0.0% from previous quarter.
  • PharmAust Limited reported quarterly long term debt of - AUD for 2024 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of PharmAust Limited (2024 - 2001)

Historical Annual Long Term Debt of PharmAust Limited (2024 - 2001)

Year Long Term Debt Long Term Debt Growth
2024 - AUD 0.0%
2023 890.5 Thousand AUD -14.13%
2022 1.03 Million AUD -8.34%
2021 1.13 Million AUD 2861.23%
2020 38.2 Thousand AUD -78.92%
2019 181.23 Thousand AUD 17897.02%
2018 1007.00 AUD -99.64%
2017 281.25 Thousand AUD -37.5%
2016 450 Thousand AUD 5596.92%
2015 7899.00 AUD -80.0%
2014 39.49 Thousand AUD 0.0%
2013 - AUD 0.0%
2012 - AUD -100.0%
2011 5358.00 AUD -85.1%
2010 35.96 Thousand AUD 0.0%
2009 - AUD 0.0%
2008 - AUD -100.0%
2007 4.47 Million AUD 1832.16%
2006 231.55 Thousand AUD 309.0%
2005 56.61 Thousand AUD 175.07%
2004 20.58 Thousand AUD 0.0%
2003 - AUD -100.0%
2002 488 Thousand AUD -29.34%
2001 690.59 Thousand AUD 0.0%

Peer Long Term Debt Comparison of PharmAust Limited

Name Long Term Debt Long Term Debt Difference
AdAlta Limited 1.08 Million AUD 100.0%
Acrux Limited - AUD NaN%
Race Oncology Limited - AUD NaN%
Biome Australia Limited - AUD NaN%
Botanix Pharmaceuticals Limited - AUD NaN%
BTC Health Limited - AUD NaN%
Chimeric Therapeutics Limited - AUD NaN%
CSL Limited 14.48 Billion AUD 100.0%
Clarity Pharmaceuticals Ltd - AUD NaN%
Clinuvel Pharmaceuticals Limited 509.92 Thousand AUD 100.0%
EZZ Life Science Holdings Limited - AUD NaN%
Hexima Limited - AUD NaN%
Immutep Limited 1.04 Million AUD 100.0%
Memphasys Limited - AUD NaN%
Neuren Pharmaceuticals Limited - AUD NaN%
Noxopharm Limited - AUD NaN%
Prescient Therapeutics Limited - AUD NaN%
Radiopharm Theranostics Limited - AUD NaN%
Starpharma Holdings Limited 1.95 Million AUD 100.0%
Tissue Repair Ltd - AUD NaN%
Biotron Limited - AUD NaN%
Alterity Therapeutics Limited 51.91 Thousand AUD 100.0%
Anatara Lifesciences Ltd - AUD NaN%
Bio-Gene Technology Limited - AUD NaN%
Zelira Therapeutics Limited 2.11 Million AUD 100.0%
Patrys Limited - AUD NaN%
Orthocell Limited 540.72 Thousand AUD 100.0%
Imugene Limited - AUD NaN%
PYC Therapeutics Limited - AUD NaN%
Proteomics International Laboratories Limited 221.03 Thousand AUD 100.0%
Cynata Therapeutics Limited - AUD NaN%
Arovella Therapeutics Limited - AUD NaN%
Nanollose Limited - AUD NaN%
Invex Therapeutics Ltd - AUD NaN%
NeuroScientific Biopharmaceuticals Limited - AUD NaN%
Amplia Therapeutics Limited 13.89 Thousand AUD 100.0%
Island Pharmaceuticals Limited - AUD NaN%
Nyrada Inc. - AUD NaN%
Telix Pharmaceuticals Limited 15.88 Million AUD 100.0%
Dimerix Limited 69.51 Thousand AUD 100.0%
AnteoTech Limited 19.22 Thousand AUD 100.0%
Paradigm Biopharmaceuticals Limited 117.48 Thousand AUD 100.0%
Recce Pharmaceuticals Ltd 587.1 Thousand AUD 100.0%
Avecho Biotechnology Limited 98.22 Thousand AUD 100.0%
Actinogen Medical Limited - AUD NaN%
Immuron Limited 132.94 Thousand AUD 100.0%
Argenica Therapeutics Limited - AUD NaN%